story of the week
20-Year Risk of Breast Cancer Recurrence After Stopping Endocrine Therapy at 5 Years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
20-Year Risks of Breast-Cancer Recurrence After Stopping Endocrine Therapy at 5 Years
N. Engl. J. Med 2017 Nov 09;377(19)1836-1846, H Pan, R Gray, J Braybrooke, C Davies, C Taylor, P McGale, R Peto, KI Pritchard, J Bergh, M Dowsett, DF HayesFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.